tradingkey.logo

tradingkey.logo
怜玢


Spero Therapeutics Inc

SPRO
りォッチリストに远加
1.000USD
0.0000.00%
終倀 11-13 16:00ET
58.23M時䟡総額
3.57盎近12ヶ月PER

Spero Therapeutics Incに぀いお 䌁業名

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying and developing novel treatments for rare diseases and diseases caused by multi-drug resistant (MDR) bacterial infections with unmet need. Its product candidate SPR720 is an investigational, chemically stable phosphate ester prodrug that is converted in vivo to SPR719 for the treatment of nontuberculous mycobacterial (NTM) pulmonary disease. Its clinical stage product candidate, tebipenem HBr is an investigational oral carbapenem antibiotic being developed for the treatment of complicated urinary tract infections (cUTIs) including acute pyelonephritis (AP) to help patients potentially reduce duration of in-patient therapy.

Spero Therapeutics Inc プロフィヌル


䌁業コヌドSPRO
䌚瀟名Spero Therapeutics Inc
䞊堎日Nov 02, 2017
最高経営責任者「CEO」Rajavelu (Esther)
埓業員数32
蚌刞皮類Ordinary Share
決算期末Nov 02
本瀟所圚地675 Massachusetts Ave Ste 14
郜垂CAMBRIDGE
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号02139-3309
電話番号18572421600
りェブサむトhttps://sperotherapeutics.com/
䌁業コヌドSPRO
䞊堎日Nov 02, 2017
最高経営責任者「CEO」Rajavelu (Esther)

Spero Therapeutics Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Ankit Mahadevia, M.D.
Dr. Ankit Mahadevia, M.D.
Non-Executive Director
Non-Executive Director
364.22K
-1.80%
Mr. Timothy (Tim) Keutzer
Mr. Timothy (Tim) Keutzer
Chief Operating Officer
Chief Operating Officer
335.13K
+55.82%
Ms. Esther Rajavelu
Ms. Esther Rajavelu
President, Chief Executive Officer, Chief Financial Officer, Treasurer and Chief Business Officer
President, Chief Executive Officer, Chief Financial Officer, Treasurer and Chief Business Officer
229.84K
-10.98%
Dr. Milind S. Deshpande, Ph.D.
Dr. Milind S. Deshpande, Ph.D.
Independent Director
Independent Director
81.45K
+12.28%
Mr. Frank E. Thomas, CPA
Mr. Frank E. Thomas, CPA
Independent Chairman of the Board
Independent Chairman of the Board
65.00K
+15.38%
Ms. Cynthia Smith
Ms. Cynthia Smith
Independent Director
Independent Director
65.00K
+15.38%
Ms. Kathleen Tregoning
Ms. Kathleen Tregoning
Independent Director
Independent Director
65.00K
+15.38%
Dr. Patrick Volkert Jozef Johannes Vink, M.D.
Dr. Patrick Volkert Jozef Johannes Vink, M.D.
Independent Director
Independent Director
--
--
Dr. John C. Pottage, Jr., M.D.
Dr. John C. Pottage, Jr., M.D.
Independent Director
Independent Director
--
--
Mr. Scott T. Jackson
Mr. Scott T. Jackson
Independent Director
Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Ankit Mahadevia, M.D.
Dr. Ankit Mahadevia, M.D.
Non-Executive Director
Non-Executive Director
364.22K
-1.80%
Mr. Timothy (Tim) Keutzer
Mr. Timothy (Tim) Keutzer
Chief Operating Officer
Chief Operating Officer
335.13K
+55.82%
Ms. Esther Rajavelu
Ms. Esther Rajavelu
President, Chief Executive Officer, Chief Financial Officer, Treasurer and Chief Business Officer
President, Chief Executive Officer, Chief Financial Officer, Treasurer and Chief Business Officer
229.84K
-10.98%
Dr. Milind S. Deshpande, Ph.D.
Dr. Milind S. Deshpande, Ph.D.
Independent Director
Independent Director
81.45K
+12.28%
Mr. Frank E. Thomas, CPA
Mr. Frank E. Thomas, CPA
Independent Chairman of the Board
Independent Chairman of the Board
65.00K
+15.38%
Ms. Cynthia Smith
Ms. Cynthia Smith
Independent Director
Independent Director
65.00K
+15.38%

よくある質問

Spero Therapeutics Incの䞊䜍5名の株䞻は誰ですか


Spero Therapeutics Incの䞊䜍5名の株䞻は以䞋のずおりです。Dr. Ankit Mahadevia, M.D.

Spero Therapeutics IncSPROの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Spero Therapeutics Incの株匏を保有しおいる機関は117瀟あり、保有株匏の総垂堎䟡倀は玄11.81Mで、党䜓の20.40%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-1291189.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。